These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 12460032)
1. The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE. Kim HL; Lee DS; Yang SH; Lim CS; Chung JH; Kim S; Lee JS; Kim YS Am J Kidney Dis; 2002 Dec; 40(6):1146-52. PubMed ID: 12460032 [TBL] [Abstract][Full Text] [Related]
2. Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis. Tucci M; Barnes EV; Sobel ES; Croker BP; Segal MS; Reeves WH; Richards HB Arthritis Rheum; 2004 Jun; 50(6):1842-9. PubMed ID: 15188361 [TBL] [Abstract][Full Text] [Related]
3. The -2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene is associated with the risk of developing systemic lupus erythematosus in Argentinean patients: a multicenter study. Aranda F; Wingeyer SP; Muñoz SA; Allievi A; Orden A; Trobo R; Alvarez A; Eimon A; Barreira JC; Schneeberger E; Sarano J; Hofman J; de Larrañaga G Eur Cytokine Netw; 2012 Mar; 23(1):7-11. PubMed ID: 22466290 [TBL] [Abstract][Full Text] [Related]
4. Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis. Alzawawy A; Zohary M; Ablordiny M; Eldalie M Int J Rheum Dis; 2009 Dec; 12(4):311-8. PubMed ID: 20374368 [TBL] [Abstract][Full Text] [Related]
5. Association of monocyte chemoattractant protein 1 (MCP-1) gene polymorphism with lupus nephritis in Egyptian patients. Mohammad LA; Atef DM; Abul-Saoud AM Hum Immunol; 2015 Oct; 76(10):724-8. PubMed ID: 26429331 [TBL] [Abstract][Full Text] [Related]
6. Association of the MCP-1 -2518 A/G polymorphism and no association of its receptor CCR2 -64 V/I polymorphism with lupus nephritis. Malafronte P; Vieira JM; Pereira AC; Krieger JE; Barros RT; Woronik V J Rheumatol; 2010 Apr; 37(4):776-82. PubMed ID: 20231199 [TBL] [Abstract][Full Text] [Related]
7. [Expression of monocyte chemoattractant protein-1 and lupus nephritis]. Liu ZJ; Lin JY Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):491-5. PubMed ID: 16178446 [TBL] [Abstract][Full Text] [Related]
8. Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis. Chan RW; Lai FM; Li EK; Tam LS; Wong TY; Szeto CY; Li PK; Szeto CC Arthritis Rheum; 2004 Sep; 50(9):2882-90. PubMed ID: 15457456 [TBL] [Abstract][Full Text] [Related]
9. Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. Kiani AN; Johnson K; Chen C; Diehl E; Hu H; Vasudevan G; Singh S; Magder LS; Knechtle SJ; Petri M J Rheumatol; 2009 Oct; 36(10):2224-30. PubMed ID: 19648301 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus. Liao CH; Yao TC; Chung HT; See LC; Kuo ML; Huang JL J Rheumatol; 2004 Oct; 31(10):2062-7. PubMed ID: 15468376 [TBL] [Abstract][Full Text] [Related]
11. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Noris M; Bernasconi S; Casiraghi F; Sozzani S; Gotti E; Remuzzi G; Mantovani A Lab Invest; 1995 Dec; 73(6):804-9. PubMed ID: 8558841 [TBL] [Abstract][Full Text] [Related]
12. Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis. Marks SD; Shah V; Pilkington C; Tullus K Pediatr Nephrol; 2010 Nov; 25(11):2283-8. PubMed ID: 20683619 [TBL] [Abstract][Full Text] [Related]
14. Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients. Rosa RF; Takei K; Araújo NC; Loduca SM; Szajubok JC; Chahade WH J Rheumatol; 2012 Oct; 39(10):1948-54. PubMed ID: 22942263 [TBL] [Abstract][Full Text] [Related]
15. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE). Schiffer L; Kümpers P; Davalos-Misslitz AM; Haubitz M; Haller H; Anders HJ; Witte T; Schiffer M Nephrol Dial Transplant; 2009 Dec; 24(12):3708-12. PubMed ID: 19602475 [TBL] [Abstract][Full Text] [Related]
16. Urinary TWEAK and the activity of lupus nephritis. Schwartz N; Su L; Burkly LC; Mackay M; Aranow C; Kollaros M; Michaelson JS; Rovin B; Putterman C J Autoimmun; 2006 Dec; 27(4):242-50. PubMed ID: 17257812 [TBL] [Abstract][Full Text] [Related]
17. MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus. Lima G; Soto-Vega E; Atisha-Fregoso Y; Sánchez-Guerrero J; Vallejo M; Vargas-Alarcón G; Llorente L Hum Immunol; 2007 Dec; 68(12):980-5. PubMed ID: 18191726 [TBL] [Abstract][Full Text] [Related]
18. The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis. Chan RW; Lai FM; Li EK; Tam LS; Chow KM; Li PK; Szeto CC Nephrol Dial Transplant; 2006 Jun; 21(6):1534-40. PubMed ID: 16449281 [TBL] [Abstract][Full Text] [Related]
19. A functional SNP MCP-1 (-2518A/G) predispose to renal disorder in Indian Systemic Lupus Erythematosus patients. Umare VD; Pradhan VD; Rajadhyaksha AG; Ghosh K; Nadkarni AH Cytokine; 2017 Aug; 96():189-194. PubMed ID: 28433894 [TBL] [Abstract][Full Text] [Related]
20. Urine chemokines as biomarkers of human systemic lupus erythematosus activity. Rovin BH; Song H; Birmingham DJ; Hebert LA; Yu CY; Nagaraja HN J Am Soc Nephrol; 2005 Feb; 16(2):467-73. PubMed ID: 15601744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]